Gilad Glick is Vice President of Venture Investments for Pharma Israel and MedTech Israel & Europe at Johnson & Johnson, where he leads equity investments and strategic partnerships in Pharma, MedTech, and Digital Health across Israel and Europe.
He previously served as CEO of Itamar Medical, guiding the sleep apnea diagnostics company through growth and its acquisition by ZOLL Medical. Earlier, he spent over 17 years at Johnson & Johnson in senior commercial and leadership roles, including Global Sales and Marketing VP at Biosense Webster.
His career spans venture investing, company leadership, and global MedTech commercialization, with a focus on scaling healthcare innovation and building partnerships across startups and large organizations.
